LIVE

Markets‘She’s a Type A personality’: My stepmother wants me to repay my late father’s $40,000 wedding gift. Should I oblige?TechMicrosoft's moolah mountain is more massive than ever. It just doesn't want the people who built it MarketsBiggest stock movers Monday: KOS, INO, and more BusinessSharon AI to Announce Third Quarter 2026 Results BusinessLa Cour fédérale de justice allemande rend une décision historique dans l'affaire opposant Alisher Usmanov au Conseil de l'UE - Rechtsanwälte Steinhöfel BusinessLUNGevity Foundation Unites Communities to Advance Progress During 2026 Lung Cancer Awareness Month BusinessTrade Your View Before the IPO: Vantage Spotlights its Pre-IPO CFD Offering MarketsCheck Point Software Technologies Non-GAAP EPS of $2.49 in-line, revenue of $669.8M misses by $2.34M Tech4 Best Alexa Speakers I’ve Tested (2026)MarketsTurkey month delivers: S&P 500 has climbed in 74% of Novembers WorldKing Charles Meets Both Joy and Criticism on Caribbean Tour LocalWhen Will We Know Election Outcomes? Don’t Hold Your Breath.LocalCan a Progressive Win a Swing State?PoliticsWe Called Back Young Men Who Voted for Trump. He’s Losing Them.LocalElon Musk Tests What Nearly Half a Billion Dollars Can Buy in the Midterms PoliticsA ‘Pugnacious’ Vance Leans Into Personal Attacks on the Campaign Trail LocalSenate Control After the Midterms: Party Switches, Ties and Wild Cards LocalParties End the Midterm Election With Their Closing Arguments LocalMidterm Elections: Who Is Winning the Race for Congress?LocalCan Democrats Flip Texas?LocalCan a Republican Win in a Democratic State?Markets5 celebrities who waited years to buy their dream homes LocalHow The New York Times Is Covering the Midterm Elections WorldDo Animals Grieve?BusinessDisneyland’s Autopia Ride Will Switch to Electric VehiclesTRENDING TICKERS: $EL $NIQ $GIL $IQMX $ROK $APP $TENX $FLNC $ASTS $BAC $HIMS $BBNX $VEEV $MSTR $FCEL $SNDK $DAVA $QBTS $BETR $LINC $NOW $DUOL $BULL $ENSG $CHKP $XPEV $FFR $GEHC $DKS $GOOGLMarkets‘She’s a Type A personality’: My stepmother wants me to repay my late father’s $40,000 wedding gift. Should I oblige?TechMicrosoft's moolah mountain is more massive than ever. It just doesn't want the people who built it MarketsBiggest stock movers Monday: KOS, INO, and more BusinessSharon AI to Announce Third Quarter 2026 Results BusinessLa Cour fédérale de justice allemande rend une décision historique dans l'affaire opposant Alisher Usmanov au Conseil de l'UE - Rechtsanwälte Steinhöfel BusinessLUNGevity Foundation Unites Communities to Advance Progress During 2026 Lung Cancer Awareness Month BusinessTrade Your View Before the IPO: Vantage Spotlights its Pre-IPO CFD Offering MarketsCheck Point Software Technologies Non-GAAP EPS of $2.49 in-line, revenue of $669.8M misses by $2.34M Tech4 Best Alexa Speakers I’ve Tested (2026)MarketsTurkey month delivers: S&P 500 has climbed in 74% of Novembers WorldKing Charles Meets Both Joy and Criticism on Caribbean Tour LocalWhen Will We Know Election Outcomes? Don’t Hold Your Breath.LocalCan a Progressive Win a Swing State?PoliticsWe Called Back Young Men Who Voted for Trump. He’s Losing Them.LocalElon Musk Tests What Nearly Half a Billion Dollars Can Buy in the Midterms PoliticsA ‘Pugnacious’ Vance Leans Into Personal Attacks on the Campaign Trail LocalSenate Control After the Midterms: Party Switches, Ties and Wild Cards LocalParties End the Midterm Election With Their Closing Arguments LocalMidterm Elections: Who Is Winning the Race for Congress?LocalCan Democrats Flip Texas?LocalCan a Republican Win in a Democratic State?Markets5 celebrities who waited years to buy their dream homes LocalHow The New York Times Is Covering the Midterm Elections WorldDo Animals Grieve?BusinessDisneyland’s Autopia Ride Will Switch to Electric VehiclesTRENDING TICKERS: $EL $NIQ $GIL $IQMX $ROK $APP $TENX $FLNC $ASTS $BAC $HIMS $BBNX $VEEV $MSTR $FCEL $SNDK $DAVA $QBTS $BETR $LINC $NOW $DUOL $BULL $ENSG $CHKP $XPEV $FFR $GEHC $DKS $GOOGL

Skip to content

Ascletis to Present Study Results of Oral Small Molecule GIPR Agonist ASC48 and GLP-1R/GIPR/GCGR Triple Peptide Agonist ASC37 at ObesityWeek® 2026

Source: PR Newswire M&A · Nov 02, 2026 08:50 UTC

The Quick Take

- Poster presentations feature preclinical in vitro and in vivo data of potentially first-in-class oral small molecule GIPR agonist ASC48 and next-generation once-monthly to once-quarterly GLP-1R/GIPR/GCGR triple peptide agonist ASC37 HONG KONG, Nov. 2, 2026 /PRNewswire/ -- Ascletis...

Read the full story at PR Newswire M&A →

Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire M&A.

Related

Sharon AI to Announce Third Quarter 2026 Results

NEW YORK, Nov. 2, 2026 /PRNewswire/ -- SharonAI Holdings Inc. (NASDAQ: SHAZ) ("Sharon AI" or the "Company"), a leading Australian Neocloud delivering trusted…

PR Newswire M&A · 5m ago

La Cour fédérale de justice allemande rend une décision historique dans l'affaire opposant Alisher Usmanov au Conseil de l'UE - Rechtsanwälte Steinhöfel

BERLIN, 2 novembre 2026 /PRNewswire/ -- La Cour fédérale de justice allemande (BGH) a jugé illégal le refus du président du tribunal régional de Hambourg de…

PR Newswire M&A · 6m ago

LUNGevity Foundation Unites Communities to Advance Progress During 2026 Lung Cancer Awareness Month

Throughout November, LUNGevity will mobilize communities nationwide to support research, expand awareness of early detection, and improve the lives of people…

PR Newswire M&A · 8m ago

Trade Your View Before the IPO: Vantage Spotlights its Pre-IPO CFD Offering

Vantage highlights how eligible clients can express long or short views before a company enters the public market. PORT VILA, Vanuatu, Nov. 2, 2026…

PR Newswire M&A · 11m ago